[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News and Perspectives
July 21, 2004

Are OTC Statins Ready for Prime Time?

JAMA. 2004;292(3):317-318. doi:10.1001/jama.292.3.317

This month, 10-mg doses of the cholesterol-lowering drug simvastatin (Zocor) are expected to become available to the public in the United Kingdom without requiring a prescription. The UK government hopes making it easier for individuals to acquire a low-cost statin (expected to cost under $1 per day; higher-dose prescription statins cost about $4) will increase the drug's use and reduce cardiovascular mortality and morbidity .

First Page Preview View Large
First page PDF preview
First page PDF preview